{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:30:54Z","timestamp":1791311454559,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chimerix"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.12.621","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T07:33:49Z","timestamp":1483688029000},"page":"512-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial"],"prefix":"10.1016","volume":"23","author":[{"given":"Michael S.","family":"Grimley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-3088","authenticated-orcid":false,"given":"Roy F.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Chittick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.12.621_bib0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bmt.1702716","article-title":"Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation","volume":"26","author":"Baldwin","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0015","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.43.4.1738-1744.2005","article-title":"Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients","volume":"43","author":"Claas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","article-title":"Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease","volume":"102","author":"Lion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198502283120901","article-title":"Adenovirus infections in patients undergoing bone-marrow transplantation","volume":"312","author":"Shields","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bmt.1705003","article-title":"Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery","volume":"36","author":"van Tol","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/169.4.775","article-title":"Increasing incidence of adenovirus disease in bone marrow transplant recipients","volume":"169","author":"Flomenberg","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0045","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/bbmt.2001.v7.pm11529489","article-title":"Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation","volume":"7","author":"Hoffman","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11908-014-0416-y","article-title":"Adenovirus: current epidemiology and emerging approaches to prevention and treatment","volume":"16","author":"Sandkovsky","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Adenovirus infections in transplant recipients","volume":"43","author":"Ison","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MPH.0b013e3181b7873e","article-title":"A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection","volume":"31","author":"Williams","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0075","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/bmt.2013.33","article-title":"Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience","volume":"48","author":"Yilmaz","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1702820","article-title":"Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children","volume":"27","author":"Legrand","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0085","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1086\/498151","article-title":"Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbmt.2006.08.040","article-title":"Treatment of adenovirus disease in stem cell transplant recipients with cidofovir","volume":"13","author":"Neofytos","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10096-004-1165-x","article-title":"Treatment of adenovirus infections in the immunocompromised host","volume":"23","author":"Ljungman","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0100","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0110","first-page":"S56","article-title":"CMX001 is a potential treatment for adenovirus infection: preliminary antiviral activity results from an open-label, expanded access study of CMX001 for the treatment of serious or life-threatening diseases caused by double-stranded DNA viruses [abstract]","volume":"48","author":"Grimley","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0120","doi-asserted-by":"crossref","first-page":"12635","DOI":"10.1128\/JVI.79.20.12635-12642.2005","article-title":"Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications","volume":"79","author":"Ebner","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2672.2009.04300.x","article-title":"Xagoraraki I. A new set of PCR assays for the identification of multiple human adenovirus species in environmental samples","volume":"107","author":"Kuo","year":"2009","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00705-005-0722-7","article-title":"Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene","volume":"151","author":"Lu","year":"2006","journal-title":"Arch Virol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/106689690301100406","article-title":"Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern","volume":"11","author":"Papadimitriou","year":"2003","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00000478-200604000-00003","article-title":"Gastric graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation?","volume":"30","author":"Welch","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0145","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.bbmt.2016.01.009","article-title":"Brincidofovir for cytomegalovirus (CMV) prophylaxis after allogeneic hematopoietic cell transplantation (HCT) in CMV-seropositive recipients: a randomized, double-blind, placebo-controlled, parallel-group phase 3 trial [abstract]","volume":"22","author":"Marty","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"S2","key":"10.1016\/j.bbmt.2016.12.621_bib9000","first-page":"169A","article-title":"Brindcidofovir (CMX001) toxicity: another potential mimicker of gastrointestinal graft versus host disease [abstract]","volume":"29","author":"Detweiler","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0150","author":"Gilead"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0155","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.05983-11","article-title":"First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses","volume":"56","author":"Painter","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-201407151-00329","article-title":"Switch from existing antivirals to brincidofovir leads to improving renal function [abstract]","volume":"98","author":"Morrison","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0170","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir is not a substrate for the human organic anion transporter 1 (OAT1): a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2016.12.621_bib0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin Microbiol Rev"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:09Z","timestamp":1761058689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116311806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116311806"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.621","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}